Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AORTIC 2015 /
Tamoxifen adherence in South Africa

18th - 22nd Nov 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.12.15
Views: 1459

Dr Sarah Rayne - Helen Joseph Breast Care Clinic, Johannesburg, South Africa

Dr Rayne talks to ecancertv at AORTIC 2015 about tamoxifen adherence in South Africa.

She says that, alarmingly, two thirds of women said they had considered stopping taking their tamoxifen when surveyed.

Women cited both side effects and transport issues among others, she says.

She argues that the benefits of the drug - namely protection against relapse - need to be properly communicated to patients to encourage them to maintain the tamoxifen regimen. 

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation